COMP <GO>
LEXX vs UPC // 10Y YIELD & FRED MACRO BETA
Lexaria Bioscience Corp. (NASDAQ) VS. Universe Pharmaceuticals Inc. (Class A) (NASDAQ) • 15-METRIC TALLY: LEXX 4
— UPC 3
■ METRIC PARITY
LAST: $3.64 (+4.30%) • MKT CAP: $7.4M
macro-sensitivity
—
LAST: $1.47 (-1.34%) • MKT CAP: $7.5M
macro-sensitivity
—
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (LEXX VS. UPC)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | LEXX | UPC | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 96.00% | 35.30% | +60.70 | LEXX | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | -35.00% | — | — | TIE | /roic <GO> |
| EV/EBITDA & P/E Valuation | — | — | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | — | — | — | TIE | /fcf-yield <GO> |
| Operating Margin | -60.00% | -16.30% | -43.70 | UPC | /operating-margins <GO> |
| Net Profit Margin | -60.00% | -20.60% | -39.40 | UPC | /net-margins <GO> |
| Revenue Growth (YoY) | 52.00% | -22.40% | +74.40 | LEXX | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | — | — | — | TIE | /balance-sheet <GO> |
| Piotroski F-Score Quality | 4/9 | 2/9 | +2.00 | LEXX | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 48.6 | 22.9 | +25.70 | LEXX | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta ACTIVE | — | — | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | — | — | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $7.4M | $7.5M | -$134.6K | UPC | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | LEXX REV | UPC REV | LEXX GROSS % | UPC GROSS % | LEXX FCF | UPC FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $705.9K | $17.86B | 98.0% | 35.3% | -$10.5M | -$5.32B |
| FY 2024 | $464.3K | $23.02B | 98.0% | 26.4% | -$5.0M | -$9.72B |
| FY 2023 | $226.2K | $32.31B | — | — | -$5.9M | $1.12B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
LEXX // BETA —
UPC // BETA —